1. Home
  2. UG vs LIXT Comparison

UG vs LIXT Comparison

Compare UG & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$6.70

Market Cap

30.2M

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.07

Market Cap

25.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
LIXT
Founded
1942
2005
Country
United States
United States
Employees
N/A
4
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.2M
25.3M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
UG
LIXT
Price
$6.70
$3.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.4K
37.7K
Earning Date
03-27-2026
05-11-2026
Dividend Yield
7.53%
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$10,545,468.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$33.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.58
$0.64
52 Week High
$9.88
$6.09

Technical Indicators

Market Signals
Indicator
UG
LIXT
Relative Strength Index (RSI) 57.11 55.15
Support Level $6.26 $2.97
Resistance Level $6.78 $3.30
Average True Range (ATR) 0.19 0.27
MACD 0.03 0.05
Stochastic Oscillator 78.21 76.47

Price Performance

Historical Comparison
UG
LIXT

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: